Minnesota, Ohio, and Missouri Leading States
CLEVELAND, Jan. 30, 2012 /PRNewswire/ -- Midwest health care companies attracted $810 Million in new investments across 178 companies in 2011 according to the BioEnterprise Midwest Health Care Venture Investment Report. The total dollars attracted is up by ten percent from 2010; however it remains below the peak year of 2007. Minnesota ($223 million), Ohio ($178 million), and Missouri ($169 million) led Midwestern states in attracting investment dollars; Minneapolis, Cleveland, and St. Louis were the leaders among Midwest regions.
(Logo: http://photos.prnewswire.com/prnh/20101028/DC90488LOGO)
"As in other regions of the country, overall health care venture activity has increased slightly but remains below historical highs," said Baiju R. Shah, President & CEO of BioEnterprise, the Cleveland-based biomedical venture developer.
By sector, the 2011 equity funding was allocated as follows:
- Medical device companies: $295 million (36%)
- Health care IT and service companies: $259 million (32%)
- Biopharmaceutical companies: $251 million (31%)
"While medical devices continues to be the Midwest's strongest sector, investors have shown an unusually high level of investment interest in Health IT opportunities. Venture investors are drawn by both providers and payers searching for health IT applications that can improve effectiveness and efficiency of their enterprises," said Shah. "At the same time, Midwest biotechs are suffering from the national venture industry's shift away from early-stage biotech investing."
The Midwest Health Care Venture Investment Report includes all reported numbers and regionally collected data. For complete state and region results across the Midwest, see the attached table. To view additional data about Midwest health care business activity visit www.bioenterprise.com/Reports/.
Table: Midwest Health Care Venture Investment (By State)
State |
2011 |
2010 |
2009 |
2008 |
2007 |
|||||
|
$ Millions |
# of Cos. |
$ Millions |
# of Cos. |
$ Millions |
# of Cos. |
$ Millions |
# of Cos. |
$ Millions |
# of Cos. |
Illinois |
44.2 |
9 |
160.9 |
11 |
38.9 |
8 |
97.3 |
13 |
125.5 |
7 |
Indiana |
14.1 |
9 |
25.05 |
16 |
76.3 |
14 |
75.4 |
7 |
135.6 |
10 |
Iowa |
- |
- |
7.3 |
1 |
36.8 |
3 |
4.0 |
1 |
- |
- |
Kansas |
18.5 |
2 |
14.5 |
13 |
4.3 |
5 |
16.9 |
9 |
56.6 |
6 |
Kentucky |
11.5 |
7 |
11.4 |
4 |
97.3 |
7 |
19.2 |
6 |
32.0 |
4 |
Michigan |
30.8 |
16 |
76.3 |
12 |
102.2 |
14 |
105.0 |
12 |
56.2 |
5 |
Minnesota |
223.3 |
24 |
138.7 |
20 |
199.0 |
23 |
318.9 |
22 |
296.1 |
25 |
Missouri |
168.7 |
9 |
19.9 |
9 |
65.8 |
8 |
50.2 |
11 |
69.6 |
7 |
Ohio |
177.8 |
67 |
147.2 |
47 |
105.4 |
40 |
189.1 |
43 |
295.5 |
44 |
Western Pennsylvania |
67.0 |
25 |
86.2 |
20 |
37.8 |
24 |
126.2 |
33 |
101.4 |
17 |
Wisconsin |
53.8 |
9 |
51.3 |
9 |
16.2 |
10 |
48.5 |
8 |
56.2 |
12 |
Total |
809.6 |
178 |
738.9 |
161 |
780.0 |
156 |
1,050.5 |
165 |
1,224.7 |
137 |
Table: Midwest Health Care Venture Investment (By Region)**
Region |
2011 |
2010 |
2009 |
2008 |
2007 |
|||||
|
$ Millions |
# of Cos. |
$ Millions |
# of Cos. |
$ Millions |
# of Cos. |
$ Millions |
# of Cos. |
$ Millions |
# of Cos. |
Chicago |
44.2 |
9 |
160.9 |
11 |
38.9 |
8 |
97.3 |
13 |
125.5 |
7 |
Indianapolis |
11.5 |
7 |
18.5 |
9 |
41.2 |
9 |
73.0 |
6 |
113.6 |
8 |
Louisville |
11.4 |
6 |
11.4 |
4 |
2.5 |
4 |
13.4 |
3 |
6.2 |
2 |
Detroit-Ann Arbor |
23.0 |
10 |
46.5 |
8 |
68.8 |
7 |
89.0 |
8 |
56.2 |
5 |
SW Michigan |
7.8 |
6 |
29.8 |
4 |
14.5 |
5 |
16.0 |
2 |
- |
- |
Minneapolis |
223.3 |
24 |
138.7 |
20 |
199.0 |
23 |
318.9 |
22 |
296.1 |
25 |
St. Louis |
112.7 |
8 |
18.9 |
9 |
27.8 |
7 |
47.2 |
10 |
57.6 |
6 |
Kansas City* |
18.5 |
2 |
15.4 |
13 |
42.3 |
6 |
19.9 |
10 |
68.6 |
7 |
Cincinnati* |
37.3 |
6 |
8.5 |
4 |
121.2 |
8 |
19.2 |
2 |
64.6 |
10 |
Cleveland |
124.7 |
40 |
135.1 |
33 |
66.3 |
21 |
163.5 |
31 |
241.8 |
28 |
Columbus |
15.1 |
19 |
3.1 |
5 |
12.4 |
13 |
6.4 |
10 |
14.2 |
7 |
Pittsburgh |
67.0 |
25 |
86.2 |
20 |
37.8 |
24 |
126.2 |
33 |
101.4 |
17 |
Wisconsin |
53.8 |
9 |
51.3 |
9 |
16.2 |
10 |
48.5 |
8 |
56.2 |
12 |
* Border MSAs such as Kansas City and Cincinnati include deals from both states in those geographies; deals are aggregated into state totals based on the MSA's principal state
**Regions' totals do not equal states as not all areas are included in list of regions
Sources: Compiled by BioEnterprise team from Venture Wire, Private Equity Week, Wall Street Journal, Venture Source, SEC Filings, company press releases, www.biospace.com, and Midwest bioscience organizations and institutions.
About BioEnterprise
BioEnterprise is a business formation, recruitment, and acceleration effort designed to support the growth of bioscience companies. Located in Cleveland, BioEnterprise provides management counsel and support services to health care companies. BioEnterprise partners are Case Western Reserve University, Cleveland Clinic, University Hospitals, Summa Health System, and the Austen BioInnovation Institute in Akron. Additional technology partners include the NASA Glenn Research Center, Cleveland State University, NorTech, and BioOhio.
The initiative comprises the collective activities of BioEnterprise and its partners' commercialization offices: the Case Office of Technology Transfer, Cleveland Clinic Innovations, University Hospitals Case Medical Center - Center for Clinical Research and ASumma Enterprise Group. The combined efforts of these groups has created, recruited, and accelerated more than 120 companies in nine years.
SOURCE BioEnterprise Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article